MedinCell S.A. (MDCLF) Financials
MDCLF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2025 | 97.9 million | 115.6 million |
| Sept. 30, 2024 | 65.6 million | 125.7 million |
| March 31, 2024 | 39.9 million | 83.9 million |
| Sept. 30, 2023 | 53.4 million | 80.7 million |
MDCLF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2025 | ? | ? |
| Sept. 30, 2024 | 23.8 million | 1.3 million |
| March 31, 2024 | -361548 | 1.7 million |
| Sept. 30, 2023 | -14.3 million | 677532 |
MDCLF Net Income
No data available :(
MDCLF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2025 | 77.8 million | 55.7 million | 2.9 million |
| Sept. 30, 2024 | 43.3 million | 58.0 million | 3.2 million |
| March 31, 2024 | 21.0 million | 57.0 million | 3.1 million |
| Sept. 30, 2023 | 28.3 million | 59.3 million | 3.2 million |
MDCLF Shares Outstanding
MDCLF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2025 | - | - | - | - |
| Sept. 30, 2024 | 217158 | 11.4 million | 7.5 million | 1.9 million |
| March 31, 2024 | 185630 | 10.7 million | 6.3 million | 1.3 million |
| Sept. 30, 2023 | 409695 | 11.1 million | 6.1 million | 745815 |
MDCLF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2025 | - | - |
| Sept. 30, 2024 | 10.5 million | - |
| March 31, 2024 | 4.1 million | 355073 |
| Sept. 30, 2023 | 7.4 million | 3.1 million |
MDCLF
Price: $34.39
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.72 USD
P/E Ratio: -47.76
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.2 billion